#007: The IPO Freeze, Tariff Volatility, Peak Private Valuations, and Colossal Biosciences
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
The IPO freeze is here. Craig unpacks the impact of tariff volatility on the IPO markets. It’s not good, at least for the time being.
He also explores the possibility that private valuations (OpenAI, Scale, and Figure AI) may have peaked. Plus, Colossal Biosciences and the de-extinction of the dire wolf.
Mentioned: Fundrise Innovation Fund
Note: There will be no new episode next week (04/19/2025) due to Spring Break. I’ll be back with a new episode on 04/26/2025.
0:00 Intro
0:50 The IPO Freeze
2:23 6 Paused IPOs
3:24 Cerebras IPO
3:58 IPO Thaw?
4:52 Volatility Index (VIX)
6:18 Maintaining S-1 Filings
8:10 IPO Pipeline
9:45 IPO Radar News
10:23 Peak Private Valuations
11:22 Figure AI WSJ
13:29 Scale AI Valuation
15:13 Colossal Biosciences
15:49 Dire Wolf
16:15 De-Extinction
16:47 Colossal Bio Funding Rounds
15:13 IPO Radar Selection
18:04 VC Investors
18:35 Colossal Bio Business Model
19:25 Dodo Bird
19:35 Can You Invest in Colossal?
20:50 Jurassic Tweet
21:10 Programming Note
21:26 Support the Show
24:04 Outro
Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. He started Access IPOs in 2016 to provide a resource for ordinary investors pursuing investment access to IPOs and pre-IPO startups. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
* This is a testimonial in partnership with Fundrise, Hiive, and other affiliate partners. We earn a commission from partner links on AccessIPOs.com. All opinions are my own. If you sign up with one of our partners through certain on this website, Access IPOs will be compensated at no additional cost to the reader. See the full disclosure here. Risk Statement: Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Access IPOs is for informational purposes only. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing.
